Delivery Order SPE2DB24D3015-SPE2DB24FFWXG
Award Date
7/11/24
Potential Completion Date
7/12/24
Potential Value
$8.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of Dupixent 300 mg/2 ml pens. The contract has a firm fixed price of $41,843.17 and an ultimate completion date of August 29, 2024. This delivery order contract is not set aside for any specific business type. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division to supply the pharmaceutical product Dupixent 300 mg/2 ml pen (2 ml). The contract, valued at $37,165.78, has a firm fixed price and is scheduled for completion by September 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of Dupixent 200 mg/1.14 ml pens. The contract is a Delivery Order with a Firm Fixed Price type, valued at $14,400.20, and has an ultimate completion date of August 28, 2024. The award is not associated with a set-aside program. As a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $8,991.84 firm fixed price delivery order is for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen (2 ml). The contract has an ultimate completion date of April 24, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, provides for the delivery of Dupixent 200 mg/1.14 ml pens for the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $18,468.00, has a completion date of September 16, 2024. It is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999 through December 2025, for supplying a comprehensive range of medical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier, is for the delivery of the drug Dupixent (300 mg/2 ml pen) to the Defense Logistics Agency (DLA). The single-award, firm-fixed-price delivery order is valued at $11,391.76 and has an ultimate completion date of May 7, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the delivery of Dupixent 300 mg/2 ml pens. The $2,679.25 Firm Fixed Price delivery order was issued by the U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical. This award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $9,655.91 firm fixed-price delivery order is for the supply of the medication Dupixent (300 mg/2 ml pen, 2 ml) to DLA facilities. This award is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen, 2 ml, with a ceiling value of $17,980.13. The award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is a delivery order against Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order, valued at $2,257.96, is for the supply of Dupixent 300 mg/2 ml pens. The contract is a firm fixed price delivery order with a performance period through March 25, 2024. Amerisourcebergen Drug Corp holds a single-award indefinite delivery contract...